Insiders · ZBIO

ZBIO insider transactions

Zenas BioPharma Inc. (ZBIO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ZBIO

• 22d
  Chief Executive Officer Moulder Leon O Jr bought $1,012,800 worth of shares (60,000 units at $16.88) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 41d
  Chief Executive Officer Moulder Leon O Jr bought $1,067,200 worth of shares (60,000 units at $17.79) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 68d
  SEC Form 4 filed by Lu Hongbo

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 69d
  SEC Form 4 filed by Fairmount Funds Management Llc

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 70d
  SEC Form 4 filed by Moulder Leon O Jr

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 70d
  SEC Form 4 filed by Lu Hongbo

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 116d
  Director Lu Hongbo bought $584,662 worth of shares (25,985 units at $22.50) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 116d
  Director Allen Patricia L bought $499,746 worth of shares (19,860 units at $25.16) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 126d
  Chief Executive Officer Moulder Leon O Jr bought $1,023,720 worth of shares (57,000 units at $17.96), increasing direct ownership by 16% to 423,155 units (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 151d
  Chief Executive Officer Moulder Leon O Jr bought $1,639,000 worth of shares (100,000 units at $16.39), increasing direct ownership by 38% to 366,155 units (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 238d
  New insider Innocare Pharma Inc. claimed ownership of 5,000,000 shares (SEC Form 3)

  3 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 238d
  Director Nunn Jason Raleigh bought $1,200,002 worth of shares (63,158 units at $19.00) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 238d
  Large owner Sr One Capital Management, Llc bought $2,399,985 worth of shares (126,315 units at $19.00) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 238d
  Director Enright Patrick G bought $2,250,026 worth of shares (117,255 units at $19.19) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 243d
  Officer Moulder Leon O Jr bought $769,949 worth of shares (36,928 units at $20.85) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 243d
  Director Fairmount Funds Management Llc bought $6,008,161 worth of shares (316,219 units at $19.00) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 243d
  Director Lu Hongbo bought $6,000,031 worth of shares (321,983 units at $18.63) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 362d
  SEC Form 4 filed by Director Nunn Jason Raleigh

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 362d
  SEC Form 4 filed by Officer Fox Jennifer A.

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 362d
  SEC Form 4 filed by Officer Oliveira Orlando

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 362d
  SEC Form 4 filed by Director Boylan James P

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 362d
  SEC Form 4 filed by Director Allen Patricia L

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 362d
  SEC Form 4 filed by Officer Farmer Joseph L

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 362d
  SEC Form 4 filed by Director Fairmount Funds Management Llc

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 362d
  SEC Form 4 filed by Director Enright Patrick G

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 362d
  SEC Form 4 filed by Director Orloff John J

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 362d
  SEC Form 4 filed by Director Lu Hongbo

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 362d
  SEC Form 4 filed by Officer Moulder Leon O Jr

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 408d
  Amendment: Director Xiao Ting bought $77,600 worth of shares (10,000 units at $7.76) (SEC Form 4)

  4/A - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 418d
  SEC Form 4 filed by Officer Von Moltke Lisa

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 445d
  SEC Form 3 filed by new insider Von Moltke Lisa

  3 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 475d
  Chief Executive Officer Moulder Leon O Jr bought $166,750 worth of shares (25,000 units at $6.67), increasing direct ownership by 10% to 266,155 units (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 483d
  Director Xiao Ting bought $77,600 worth of shares (10,000 units at $7.76), increasing direct ownership by 27% to 47,000 units (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 538d
  SEC Form 4 filed by Officer Fox Jennifer A.

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 538d
  SEC Form 4 filed by Chief Commercial Officer Oliveira Orlando

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 552d
  Chief Executive Officer Moulder Leon O Jr bought $718,100 worth of shares (70,000 units at $10.26), increasing direct ownership by 41% to 241,155 units (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 566d
  Chief Executive Officer Moulder Leon O Jr bought $148,925 worth of shares (10,000 units at $14.89), increasing direct ownership by 6% to 171,155 units (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 627d
  Chief Executive Officer Moulder Leon O Jr bought $360,820 worth of shares (20,000 units at $18.04) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 630d
  Amendment: Director Fairmount Funds Management Llc converted options into 1,304,891 shares and bought $5,100,000 worth of shares (300,000 units at $17.00) (SEC Form 4)

  4/A - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 630d
  Amendment: Chief Executive Officer Moulder Leon O Jr converted options into 693,175 shares, increasing direct ownership by 3,465% to 161,155 units (SEC Form 4)

  4/A - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 630d
  Director Lu Hongbo bought $999,991 worth of shares (58,823 units at $17.00) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 631d
  SEC Form 4 filed by Director Orloff John J

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 631d
  SEC Form 4 filed by Director Xiao Ting

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 631d
  SEC Form 4 filed by Director Lu Hongbo

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 631d
  SEC Form 4 filed by Director Allen Patricia L

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 631d
  Director Enright Patrick G converted options into 2,061,934 shares and bought $7,480,000 worth of shares (440,000 units at $17.00) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 631d
  SEC Form 4 filed by Director Boylan James P

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 631d
  Director Nunn Jason Raleigh converted options into 2,174,449 shares and bought $14,999,984 worth of shares (882,352 units at $17.00) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 631d
  Director Fairmount Funds Management Llc converted options into 1,304,891 shares and bought $5,100,000 worth of shares (300,000 units at $17.00) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 631d
  SEC Form 4 filed by Chief Commercial Officer Oliveira Orlando

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 631d
  Large owner Sr One Capital Management, Llc converted options into 2,676,245 shares and bought $37,999,998 worth of shares (2,235,294 units at $17.00) (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 631d
  SEC Form 4 filed by Officer Farmer Joseph L

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 631d
  SEC Form 4 filed by Officer Fox Jennifer A.

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
• 631d
  Chief Executive Officer Moulder Leon O Jr converted options into 693,175 shares (SEC Form 4)

  4 - Zenas BioPharma, Inc. (0001953926) (Issuer)